Researchers suggest treating the earliest signs of multiple sclerosis with interferon beta-1b could reduce the risk of diagnosis and reduce relapse rate.
Researchers suggest treating the earliest signs of multiple sclerosis with interferon beta-1b could reduce the risk of diagnosis and reduce relapse rate.
